Should Pre-Transplant Hemoglobin A(1c) Be Used to Predict Post-Transplant Compliance in End-Stage Renal Disease Patients Undergoing Kidney Transplantation?

BACKGROUND: Patient compliance with immunosuppressive therapy after transplant has impacts on both graft and patient outcomes. For diabetic end-stage renal disease (ESRD) patients who are undergoing evaluation for kidney transplantation in our program, hemoglobin A(1c) (HbA(1c)) level of >10% is...

Descripción completa

Detalles Bibliográficos
Autores principales: Terranella, Samantha L., Poirier, Jennifer, Chan, Edie Y., Hertl, Martin, Olaitan, Oyedolamu K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2020
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7339972/
https://www.ncbi.nlm.nih.gov/pubmed/32587234
http://dx.doi.org/10.12659/AOT.924061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7339972/
https://www.ncbi.nlm.nih.gov/pubmed/32587234
http://dx.doi.org/10.12659/AOT.924061

Ejemplares similares